Long-term follow-up of the FAST-Trial; catheter ablation and surgical ablation for the treatment of atrial fibrillation

Long-term follow-up of the FAST-Trial; catheter ablation and surgical ablation for the treatment of atrial fibrillation - Long-term follow-up of the FAST-Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42695

Enrollment

Registered

2015-12-01

Start date

2016-01-06

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation heart rhythm disorder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: It includes the original included population of 124 patients that participated in the FAST trial.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
• Freedom from any left atrial arrhythmia with or without the use of anti-arrhythmic drugs • Freedom from additional catheter ablation or rhythm surgery	—

Secondary

Measure	Time frame
• Freedom from MACE; Cardiovascular death, Myocardial infarction, Recurrent ischemia requiring PCI or surgery • Freedom from ischemic stroke • Freedom from transient ischemic attack • Freedom from cerebral bleeding • Freedom from major bleeding needing transfusion • Overall survival • Freedom from pacemaker implantation • Freedom from any LA arrhythmia with or without the use of OAC • QOL	—

Measure

Time frame

• Freedom from MACE; Cardiovascular death, Myocardial infarction, Recurrent ischemia requiring PCI or surgery • Freedom from ischemic stroke • Freedom from transient ischemic attack • Freedom from cerebral bleeding • Freedom from major bleeding needing transfusion • Overall survival • Freedom from pacemaker implantation • Freedom from any LA arrhythmia with or without the use of OAC • QOL

—

Countries

Netherlands

Outcome results